Arrowhead Pharmaceuticals’ (ARWR) “Buy” Rating Reaffirmed at B. Riley
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at B. Riley in a report issued on Friday,Benzinga reports. They currently have a $38.00 target price on the biotechnology company’s stock, down from their previous target price of $51.00. B. Riley’s target price points to a potential upside […]
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at B. Riley in a report issued on Friday,Benzinga reports. They currently have a $38.00 target price on the biotechnology company’s stock, down from their previous target price of $51.00. B. Riley’s target price points to a potential upside […]
